The Latest Breaking News from diabetes

Finerenone Kidney Drug Shown to Protect Heart and Kidneys in Millions More Patients After Three Major 2026 Studies

Three major studies published in NEJM, JAMA, and The Lancet in June 2026 show finerenone protects kidneys and hearts in non-diabetic CKD patients, expanding its potential reach to millions.

Medical Daily · Jun 10

New daily weight loss pill helps people shed 10 per cent of body weight

The pill doesn’t have the fasting requirements of many other weight loss drugs

The Independent UK · Jun 10

What is PMOS (formerly PCOS)? What to know about the hormonal syndrome

Learn about the hormonal disorder polyendocrine metabolic ovarian syndrome (PMOS), formerly called polycystic ovary syndrome (PCOS).

LiveScience · Jun 9

Attorneys urge release of mosque leader, saying he's been denied diabetes care in ICE custody

Attorneys for the president of Wisconsin's largest mosque say he is being denied basic medical care for diabetes and has lost 30 pounds since he was taken into custody two months ago by U.S. Immigration and Customs Enforcement

The Independent UK · Jun 9

US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients ‌with obesity, ⁠at the ⁠American Diabetes Association meeting in New Orleans.

The Economic Times · Jun 8

Why You're Always Exhausted Even After a Full Night's Sleep

You go to bed on time, sleep for seven to nine hours, and expect to wake up feeling refreshed. Instead, you drag yourself out of bed, reach for another cup of coffee, and spend the day feeling drained. If this sounds familiar, you're not alone. Many people experience constant tiredness…

MyLifeXP · Jun 8

Stanford Study Identifies Why Ozempic and Wegovy Don't Work in About 1 in 10 Patients

A Stanford Medicine study identifies a genetic variant in about 10% of people that may reduce response to GLP-1 drugs like Ozempic and Wegovy, offering new insight into why these widely used diabetes and weight-loss treatments fail for some patients and highlighting the future of precision medicine in Type 2…

Medical Daily · Jun 7

Triple-action diabetes jab shown to reduce blood sugar and body weight

Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugs

The Guardian - UK · Jun 7

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoarthritis pain in adults with obesity. Patients also experienced substantial weight loss. These findings were shared at an American Diabetes Association conference. Retatrutide targets multiple hormones related to obesity and…

The Economic Times · Jun 7

In 26 Days, Hundreds of Thousands of LA County Residents Will Lose Medi-Cal Dental Coverage — And Most Don't Know It's Happening

Hundreds of thousands of Los Angeles Medi-Cal beneficiaries could lose dental coverage on July 1, 2026, raising concerns about worsening diabetes, oral health complications, and reduced access to preventive care.

Medical Daily · Jun 6